See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2020_Biospecifics_Technologies_CORP.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000875622, Biospecifics Technologies CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 109,271,476 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 573,277 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 16,808,515 |
| 4 | LiabilitiesCurrent | 1,422,492 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,292,123 |
| 9 | ResearchAndDevelopmentExpense | 537,050 |
| 10 | remainder_Expenses | 5,670,784 |
| 11 | remainder_Revenues | 39,805,104 |
| 12 | remainder_NetIncome | 4,922,170 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 126,653,268 |
| 1 | Liabilities | 1,422,492 |
| 2 | Expenses | 15,499,957 |
| 3 | Revenues | 39,805,104 |
| 4 | StockholdersEquity | 125,230,776 |
| 5 | NetIncome | 29,227,317 |
| 6 | ComprehensiveNetIncome | 29,227,317 |
| 7 | BaseVar | 94,151,496 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.72 |
| 9 | EconomicCapitalRatio | 4.96 |
Edgar->Model Mapping
Feature Distribution
Change over Time
